Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Non-Current Assets (2021 - 2022)

Bioventus' Other Non-Current Assets history spans 2 years, with the latest figure at $2.8 million for Q4 2022.

  • For Q4 2022, Other Non-Current Assets fell 94.45% year-over-year to $2.8 million; the TTM value through Dec 2022 reached $2.8 million, down 94.45%, while the annual FY2022 figure was $2.8 million, 94.45% down from the prior year.
  • Other Non-Current Assets reached $2.8 million in Q4 2022 per BVS's latest filing, down from $50.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $50.0 million in Q4 2021 to a low of $2.8 million in Q4 2022.